Home » Marché des métastases osseuses

Marché des métastases osseuses par type (métastases osseuses ostéolytiques, métastases osseuses ostéoblastiques, métastases osseuses mixtes) ; par origine / cancer primaire (cancer du sein, cancer de la prostate, cancer du poumon, cancer du rein, cancer de la thyroïde, autres cancers primaires) ; par diagnostic (imagerie, biopsie, analyses de sang, autres) ; par traitement / thérapie (thérapie pharmacologique, radiothérapie, thérapie médicale systémique, thérapies d’ablation locale/minimale invasive, interventions chirurgicales et orthopédiques, soins de soutien et palliatifs) ; par utilisateur final (hôpitaux et centres de cancérologie, cliniques spécialisées et orthopédiques, cliniques oncologiques communautaires, centres de chirurgie ambulatoire, soins à domicile) ; par région – croissance, part, opportunités et analyse concurrentielle, 2025 – 2032

Report ID: 204258 | Report Format : Excel, PDF
Demander un échantillon gratuit

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Demandez votre rapport d’échantillon et commencez votre parcours de décisions éclairées


Fournir la boussole stratégique pour les géants de l’industrie.

cr-clients-logos
Questions Fréquemment Posées :
Quelle est la taille du marché des métastases osseuses en 2025 et les prévisions pour 2032 ?

La taille du marché des métastases osseuses était de 19 984,63 millions USD en 2025 et devrait atteindre 31 260,54 millions USD d’ici 2032.

Quel est le TCAC du marché des métastases osseuses entre 2025 et 2032 ?

Le marché des métastases osseuses devrait croître à un taux de croissance annuel composé (CAGR) de 6,6 % de 2025 à 2032.

Quel est le segment le plus important sur le marché des métastases osseuses ?

L’imagerie est le plus grand segment de diagnostic avec une part estimée à 72,9 % en 2025.

Quels facteurs stimulent la croissance du marché des métastases osseuses ?

La croissance est alimentée par l’augmentation de la prévalence du cancer métastatique, une survie plus longue dans les maladies avancées, des flux de travail de détection et de surveillance guidés par l’imagerie, et l’utilisation croissante de voies de gestion systémique et de soutien des os.

Quelles entreprises sont des participants principaux sur le marché des métastases osseuses ?

Les entreprises clés comprennent Amgen Inc., Novartis AG, F. Hoffmann-La Roche Ltd (Roche), Pfizer Inc., Merck & Co., Inc., Bayer AG, Eli Lilly and Company, Johnson & Johnson / Janssen, Medtronic plc, Boston Scientific Corporation, GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., et BTG plc.

Quelle région domine le marché des métastases osseuses ?

L’Amérique du Nord domine le marché des métastases osseuses avec une part estimée à 36,2 % en 2025.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Oral Macromolecular Formulation Market

The Oral Macromolecular Formulation market size was valued at USD 9 million in 2024 and is projected to reach USD 12.51 million by 2032, reflecting a CAGR of 4.8% during the forecast period.

Ineffective Esophageal Motility Treatment Market

The Ineffective Esophageal Motility Treatment market size was valued at USD 4,680 million in 2024 and is projected to reach USD 7,402.47 million by 2032, growing at a CAGR of 5.9% during the forecast period.

At-Home Molecular Testing Market

At Home Molecular Testing market size was valued at USD 10,809 million in 2024 and is anticipated to reach USD 16,463.2 million by 2032, growing at a CAGR of 5.4% during the forecast period.

OTC Cough Cold And Allergy Medicine Market

The global OTC cough, cold, and allergy medicine market was valued at USD 23,450 million in 2024 and is projected to reach USD 32,590.02 million by 2032, expanding at a compound annual growth rate (CAGR) of 4.2% during the forecast period.

Novel Cardiovascular Drug Delivery Devices Market

Novel Cardiovascular Drug Delivery Devices Market size was valued USD 5189 million in 2024 and is anticipated to reach USD 9322.84 million by 2032, at a CAGR of 7.6% during the forecast period.

Small Molecule Injectable Market

The Small Molecule Injectable market was valued at USD 141,836 million in 2024 and is anticipated to reach USD 241,884.7 million by 2032, growing at a CAGR of 6.9% during the forecast period.

Nanoparticle Formulation Market

Nanoparticle Formulation Market size was valued USD 8589 million in 2024 and is anticipated to reach USD 16863.73 million by 2032, at a CAGR of 8.8% during the forecast period.

Autologous Conditioned Plasma (ACP) Market

Autologous Conditioned Plasma (ACP) Market size was valued USD 584 million in 2024 and is anticipated to reach USD 1366.31 million by 2032, at a CAGR of 11.2% during the forecast period.

Autogenous Vaccine Market

Autogenous Vaccine Market size was valued USD 465 million in 2024 and is anticipated to reach USD 810.46 million by 2032, at a CAGR of 7.2% during the forecast period.

Combination Therapies In Aesthetics Market

The global combination therapies in aesthetics market was valued at USD 3,690 million in 2024 and is projected to reach USD 6,880.69 million by 2032, expanding at a compound annual growth rate (CAGR) of 8.1% during the forecast period.

Antioxidants Market

The global antioxidants market was valued at USD 4,095.8 million in 2024 and is anticipated to reach USD 6,657.29 million by 2032, expanding at a CAGR of 6.26% during the forecast period.

U.S. Pharma R&D Outsourcing Market

US Pharma R&D Outsourcing Market size was valued at USD 30,916.90 Million in 2024 and is anticipated to reach USD 67,782.11 Million by 2032, at a CAGR of 10.31% during the forecast period.

Option de licence

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$7999

Report delivery within 24 to 48 hours

Europe

North America

Email

Smallform of Sample request
User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Scientifique des matériaux
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Assistant de direction, Bekaert

cr-clients-logos

Request Sample